1
|
Ameen RQ, Amin ZA, Ahmad HO, Ghafur DD, Toma MG, Sabah N, Fakhir M, Abdulla G. Gastroprotective effect of rhodanine and 2,4-thiazolidinediones scaffolds in rat stomachs by contribution of anti-apoptotic (BCL-2) and tumor suppressor (P53) proteins. Sci Rep 2024; 14:1699. [PMID: 38242960 PMCID: PMC10799065 DOI: 10.1038/s41598-024-51446-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/12/2023] [Accepted: 01/04/2024] [Indexed: 01/21/2024] Open
Abstract
In recent times, the methods used to evaluate gastric ulcer healing worldwide have been based on visual examinations and estimating ulcer dimensions in experimental animals. In this study, the protective effect of rhodanine and 2,4-thiazolidinediones scaffolds compared to esomeprazole was investigated in an ethanol model of stomach ulcers in rats. Pretreatment with experimental treatments or esomeprazole prevented the development of ethanol-induced gastric ulcers. The severity of the lesions and injuries was significantly lower than that of vehicle (10% Tween 80) treated rats. Significant and excellent results were obtained with the compound 6 group, with inhibition percentage and ulcer area values of 97.8% and 12.8 ± 1.1 mm2, respectively. Synthesized compounds 2, 7 and 8 exhibited inhibition percentages and ulcer areas of 94.3% and 31.2 ± 1.1 mm2, 91. 3% and 48.1 ± 0. 8 mm2, 89. 5% and 57. 6 ± 1. 2 mm2, and 89. 1% and 60.3 ± 0. 8 mm2, respectively. These biological outcomes are consistent with the docking studies in which Compounds 7 and 8 showed remarkable binding site affinities toward human H+/K+-ATPase α protein (ID: P20648), rat H+/K+-ATPase α protein (ID: P09626), and Na+/K+-ATPase crystal structure (PDB ID:2ZXE) with binding site energies of - 10.7, - 9.0, and - 10.4 (kcal/mol) and - 8.7, - 8.5, and - 8.0 (kcal/mol), respectively. These results indicate that these test samples were as effective as esomeprazole. Likewise, immunohistochemical staining of antiapoptotic (BCL2) and tumor suppressor (P53) proteins showed strong positive marks in the10% Tween 80- treated group, opposing the mild staining results for the esomeprazole-treated group. Similarly, the staining intensity of the group treated with Compounds 2-8 was variable for both proteins.
Collapse
Affiliation(s)
- Rozh Q Ameen
- Department of Pharmacy, Paitaxt Technical Institute, Erbil, Kurdistan Region, Iraq
| | - Zahra A Amin
- Department of Clinical Analysis, College of Pharmacy, Hawler Medical University, Erbil, Kurdistan Region, 44001, Iraq
| | - Hiwa O Ahmad
- Department of Pharmaceutical Chemistry, College of Pharmacy, Hawler Medical University, Erbil, Kurdistan Region, 44001, Iraq.
- Pharmacy Department, College of Medicine, University of Kurdistan- Hewlêr, Erbil, Kurdistan Region, Iraq.
| | - Diler D Ghafur
- Department of Chemistry, College of Education, Salahaddin University, Erbil, Kurdistan Region, Iraq
| | - Melodya G Toma
- Department of Pharmaceutical Chemistry, College of Pharmacy, Hawler Medical University, Erbil, Kurdistan Region, 44001, Iraq
| | - Nyan Sabah
- Department of Clinical Analysis, College of Pharmacy, Hawler Medical University, Erbil, Kurdistan Region, 44001, Iraq
| | - Muhammad Fakhir
- Department of Clinical Analysis, College of Pharmacy, Hawler Medical University, Erbil, Kurdistan Region, 44001, Iraq
| | - Gardoon Abdulla
- Department of Pharmaceutical Chemistry, College of Pharmacy, Hawler Medical University, Erbil, Kurdistan Region, 44001, Iraq
| |
Collapse
|
2
|
de Terlizzi M, Toma MG, Santostasi T, Colella R, Ceci A, De Benedictis G. Angioimmunoblastic lymphadenopathy with dysproteinemia: report of a case in infancy with review of literature. Pediatr Hematol Oncol 1989; 6:37-44. [PMID: 2701700 DOI: 10.3109/08880018909014579] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/02/2023]
Abstract
A case of angioimmunoblastic lymphadenopathy with dysproteinemia (AILD) in infancy is reported. The disease had a mild onset with generalized lymphadenopathy, hepatosplenomegaly, thrombocytopenia, polyclonal hypergammaglobulinemia, and T-cell deficiency. The AILD course lasted more than 100 months, alternating clinical remission to recurrent relapses. Hepatitis B viral infection suddenly evolving to hepatic failure was the cause of death. From a rapid survey of the present knowledge, the nosology, immunological features, and therapy of AILD are discussed and a possible presumptive pathogenetic pathway is proposed.
Collapse
Affiliation(s)
- M de Terlizzi
- Department of 2nd Pediatrics, University of Bari, Italy
| | | | | | | | | | | |
Collapse
|
3
|
Ceci A, de Terlizzi M, Colella R, Balducci D, Toma MG, Zurlo MG, Macchia P, Mancini A, Indolfi P, Locurto M. Etoposide in recurrent childhood Langerhans' cell histiocytosis: an Italian cooperative study. Cancer 1988; 62:2528-31. [PMID: 3056605 DOI: 10.1002/1097-0142(19881215)62:12<2528::aid-cncr2820621213>3.0.co;2-#] [Citation(s) in RCA: 61] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/03/2023]
Abstract
Eighteen evaluable children with recurrent Langerhans' cell histiocytosis (LCH) which was resistant to standard therapy, were treated with etoposide (VP 16-213), 200 mg/m2/day for 3 days every 3 weeks, to study the efficacy and toxicity of this drug. Complete and partial responses were demonstrated in 15 patients (83.3%). Only one of the 12 children achieving a complete remission has relapsed. No dose-limiting major toxicities were registered. Although etoposide might be an effective treatment in recurrent LCH which needs a chemotherapeutic approach, it is emphasized that this drug must be used carefully.
Collapse
Affiliation(s)
- A Ceci
- Second Department of Pediatrics, University of Bari, Italy
| | | | | | | | | | | | | | | | | | | |
Collapse
|
4
|
de Terlizzi M, Philip T, Toma MG, Colella R, Ceci A. [Massive therapy and transplant of autologous bone marrow in childhood lymphomas and solid tumors. State of the art and perspectives]. Pediatr Med Chir 1988; 10:359-64. [PMID: 3068631] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/04/2023] Open
Abstract
The role of massive therapy followed by autologous bone marrow transplantation (ABMT) in pediatric tumours is reviewed. The rationale of such an approach based on dose-response relationship in clinical oncology, the usefulness of total body irradiation (TBI) as a part of conditioning regimens, and phase I and II trials with high dose drug combinations are discussed. The results of ABMT in lymphomas, sarcomas, neuroblastomas and other tumours are critically analyzed with special emphasis on prognostic factors, differences among conditioning regimens, intensive therapy morbidity and marrow purging procedures. Finally future perspectives and questions still unsolved are briefly summarized.
Collapse
Affiliation(s)
- M de Terlizzi
- Bone Marrow Transplant Unit, Centre Léon Bérard, Lyon, Francia
| | | | | | | | | |
Collapse
|
6
|
Ceci A, de Terlizzi M, Toma MG, Calculli G, Caputo R, Castello M, Indolfi P, Rosati D. Heterogeneity of immunological patterns in Langerhan's histiocytosis and response to crude calf thymic extract in 11 patients. Med Pediatr Oncol 1988; 16:111-5. [PMID: 3258401 DOI: 10.1002/mpo.2950160209] [Citation(s) in RCA: 14] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/04/2023]
Abstract
Response to treatment with daily intramuscularly administered crude calf thymic extract (Suppressin) in 11 patients with Langerhan's histiocytosis (L.H.) is reported. In ten patients, T-lymphocytic subsets were studied before starting immunotherapy: OKT3 positive and OKT4 positive cells were reduced in four patients; OKT8 positive cells were reduced in two patients; three patients were normal. After immunotherapy, one patient entered complete remission, four patients had stationary disease, and six had marked clinical progression. Subsequently eight patients underwent conventional chemotherapy, and only three entered complete remission. This study has demonstrated the heterogeneity of immunological patterns in L.H. and justifies the necessity for investigations on the immunoregulatory mechanism of L.H.
Collapse
Affiliation(s)
- A Ceci
- 2nd Pediatric Department, University of Bari, Italy
| | | | | | | | | | | | | | | |
Collapse
|